Skip to main content
. 2017 Jan 23;38(4):551–560. doi: 10.1038/aps.2016.139

Figure 5.

Figure 5

Chromopeptide A impairs prostate cancer cell migration in a dose-dependent manner. (A, B) PC3 cells were planted in the upper transwell chamber and treated with indicated concentrations of chromopeptide A or FK228. Cells were allowed to migrate for 24 h; then, migrated cells were stained and observed under a microscope (×200) (A) and cell numbers were counted (B). Bars represent the mean±SD. *P<0.05, **P<0.01.